Arcutis Biotherapeutics, Inc. (ARQT)
24.79
-0.29
(-1.16%)
USD |
NASDAQ |
Aug 24, 16:00
24.79
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Price to Book Value : 14.11 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 14.28 |
| August 20, 2026 | 14.43 |
| August 19, 2026 | 15.07 |
| August 18, 2026 | 15.11 |
| August 17, 2026 | 14.58 |
| August 14, 2026 | 14.91 |
| August 13, 2026 | 14.71 |
| August 12, 2026 | 14.96 |
| August 11, 2026 | 14.93 |
| August 10, 2026 | 14.76 |
| August 07, 2026 | 14.40 |
| August 06, 2026 | 15.05 |
| August 05, 2026 | 15.43 |
| August 04, 2026 | 14.82 |
| August 03, 2026 | 14.77 |
| July 31, 2026 | 15.29 |
| July 30, 2026 | 15.94 |
| July 29, 2026 | 15.86 |
| July 28, 2026 | 16.18 |
| July 27, 2026 | 15.85 |
| July 24, 2026 | 15.57 |
| July 23, 2026 | 15.56 |
| July 22, 2026 | 15.89 |
| July 21, 2026 | 16.09 |
| July 20, 2026 | 15.67 |
| Date | Value |
|---|---|
| July 17, 2026 | 16.22 |
| July 16, 2026 | 15.79 |
| July 15, 2026 | 15.82 |
| July 14, 2026 | 15.26 |
| July 13, 2026 | 15.44 |
| July 10, 2026 | 15.79 |
| July 09, 2026 | 16.39 |
| July 08, 2026 | 16.23 |
| July 07, 2026 | 15.75 |
| July 06, 2026 | 14.84 |
| July 02, 2026 | 14.70 |
| July 01, 2026 | 14.71 |
| June 30, 2026 | 14.93 |
| June 29, 2026 | 17.64 |
| June 26, 2026 | 17.80 |
| June 25, 2026 | 17.60 |
| June 24, 2026 | 18.05 |
| June 23, 2026 | 17.32 |
| June 22, 2026 | 17.58 |
| June 18, 2026 | 17.28 |
| June 17, 2026 | 17.29 |
| June 16, 2026 | 16.93 |
| June 15, 2026 | 16.87 |
| June 12, 2026 | 16.07 |
| June 11, 2026 | 16.21 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.903 |
| Insmed, Inc. | 35.74 |
| Emergent BioSolutions, Inc. | 0.7768 |
| Exelixis, Inc. | 7.366 |
| Vertex Pharmaceuticals, Inc. | 6.854 |
Price to Book Value Related Metrics
| PE Ratio | 119.70 |
| PS Ratio | 7.130 |
| Price to Free Cash Flow | 84.50 |
| Price | 24.79 |
| Earnings Yield | 0.84% |
| Market Cap | 3.113B |
| Operating PE Ratio | 96.58 |
| Normalized PE Ratio | 119.47 |